Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?

Conference Correspondent  - Breast Cancer, Video, SABCS
Matthew P. Goetz, MD
Dr Matthew Goetz reviews what differentiates abemaciclib, the latest CDK4/6 inhibitor FDA-approved for HR+ metastatic breast cancer, from ribociclib and palbociclib.
Related Items
An Expert Perspective on the Current and Future of Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Paula Anastasia, RN, MN, AOCN, Ali McBride, PharmD, MS, BCPS
Videos published on November 30, 2020 in Interview with the Innovators, Video
2020 Year in Review - Breast Cancer
2020 Year in Review - Breast Cancer published on November 28, 2020 in Breast Cancer
JHOP Year in Review Article Sample
2020 Year in Review - Breast Cancer published on November 16, 2020 in Breast Cancer
JHOP Year in Review Article Sample2
2020 Year in Review - Breast Cancer published on November 16, 2020 in Breast Cancer
JHOP Year in Review Article Sample3
2020 Year in Review - Breast Cancer published on November 16, 2020 in Breast Cancer
Immunotherapy in Combination with PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Paula Anastasia, RN, MN, AOCN, Ali McBride, PharmD, MS, BCPS
Videos published on November 13, 2020 in Interview with the Innovators, Video
Surgery and Radiation Do Not Extend Survival in Newly Diagnosed Stage IV Breast Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6 published on November 9, 2020 in Breast Cancer
Adverse Events and Improvements in Quality of Life Associated with First-Line Maintenance Therapy in Ovarian Cancer
Paula Anastasia, RN, MN, AOCN, Ali McBride, PharmD, MS, BCPS
Videos published on November 2, 2020 in Interview with the Innovators, Video
Management of Adverse Events Associated with PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
Ali McBride, PharmD, MS, BCPS, Paula Anastasia, RN, MN, AOCN
Videos published on October 11, 2020 in Interview with the Innovators, Video
Combination Therapy as Maintenance in Ovarian Cancer
Amina Ahmed, MD, Ali McBride, PharmD, MS, BCPS, Paula Anastasia, RN, MN, AOCN
Videos published on October 6, 2020 in Interview with the Innovators, Video
Last modified: April 27, 2020